TB-500 is a synthetic peptide modeled after thymosin beta-4 and is frequently studied for its influence on cell migration, actin regulation, and muscle repair processes
Updated June 2026 Clinical data & FDA See all Retatrutide Phase 3 Results 2026: TRIUMPH Trial Tracker Living tracker of every retatrutide trial TRIUMPH-1/2/3/4/5, TRIUMPH-Outcomes, TRANSCEND-T2D-1/2, and SYNERGY-OUTCOMES Phase 3 readouts
They could add to or even replace injectable treatments
Only around 0.4% to 1% of each dose is absorbed even under optimal conditions
Researchers are exploring its potential in addressing visceral fat, hepatic lipid accumulation, and insulin resistance (Ruocco et al
In addition to his work with patients and practitioners at Central Drugs, Nayan is involved with the USC School of Pharmacy as a guest lecturer and faculty member.